Supporting Information a Novel Strategy for Facile Serum Exosome

Total Page:16

File Type:pdf, Size:1020Kb

Supporting Information a Novel Strategy for Facile Serum Exosome Electronic Supplementary Material (ESI) for Chemical Science. This journal is © The Royal Society of Chemistry 2018 Supporting Information A novel strategy for facile serum exosome isolation based on specific interactions between phospholipid bilayers and TiO2 Fangyuan Gao, ‡a Fenglong Jiao, ‡ab Chaoshuang Xia,a Yang Zhao,a Wantao Ying,a Yuping Xie,a Xiaoya Guan, c Ming Tao, d Yangjun Zhang, *a Weijie Qin, *a Xiaohong Qian, *a a. State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing Proteome Research Center. E-mail: [email protected]; [email protected]; [email protected]. b. School of Life Science and Technology, Beijing Institute of Technology. c. Peking University Cancer Hospital. d. Peking University Third Hospital. ‡ These authors contributed equally. 1 Table of Contents 1. Supplemental Fig. S1 Isolation and characterization of exosomes from HeLa cells culture medium. 2. Supplemental Fig.S2 SDS-PAGE analysis (silver stained) of the proteins isolated from model sample by TiO2 microspheres. 3. Supplemental Fig. S3 SDS-PAGE images of (A) α-casein (1 μg), β-casein (1 μg) and horseradish peroxidase (1 μg). (B) the model exosomal proteins (2 μg), mixture of the model exosomal proteins (2 μg)+α-casein (1 μg)+ β-casein (1 μg)+horseradish peroxidase (1 μg), and mixture of the model exosomal protein (2 μg)+α-casein (1 μg)+β-casein (1 μg)+horseradish peroxidase (1 μg) after isolated by TiO2. 4. Supplemental Fig. S4 SDS-PAGE image of the proteins extracted from the exosomes isolated by TiO2 in three replicates (Lane 1, 3 and 5) and the corresponding residual proteins on TiO2 after exosome elution (Lane2, 4, 6). 5. Supplemental Fig. S5 Exosome enrichment effect by using (A) different TiO2 amounts and (B) different incubation time (evaluated by Western Blot analysis of TSG101). 6. Supplemental Fig. S6 Exosome isolation using different commercial titanium dioxide particles. 7 Supplemental Fig. S7 Schematic of the TiO2-based method for exosomes isolation and downstream analyses. 8 Supplemental Fig. S8 Gene Ontology analysis of cellular components of proteins identified in exosomes obtained by different methods. 9. Supplemental Table S1 Brief Comparison of Various Exosome Isolation Methods. 10. Supplemental Table S2 Numbers of protein groups identified under different conditions. 11. Supplemental Table S3 Significantly regulated serum exosomal proteins in pancreatic cancer. 12. References 2 A B D HeLa cell culture medium kDa M Cell Exo 180 300 g, 10 min cells 130 95 Supernatant 72 55 2,000 g, 10 min 43 dead cells Supernatant 34 26 cells debris 10,000 g, 30 min 100 nm Supernatant 17 C 1E+0 100,000 g, 70 min 9E-1 e v 8E-1 i Crude exosomes t a E l 7E-1 e R 6E-1 Cell Exo wash in PBS 100,000 g, 70 min n o i t 5E-1 CD81 a r t n 4E-1 e CD81 c TSG101 n 3E-1 wash in PBS 100,000 g, 70 min o C 2E-1 PHB1 Exosomes 1E-1 0E+0 β-actin 5 10 100 1000 2000 Diameter/nm Supplemental Fig. S1 Isolation and characterization of exosomes from HeLa cells culture medium. (A) Workflow for isolation of exosomes using ultracentrifugation. (B) TEM image of exosomes. (C) NTA measurement of the size distribution of exosomes. (D) Coomassie Brilliant Blue stained 12% SDS- PAGE analysis of HeLa cell lysates and exosome proteins. (E) Western blotting analysis of common exosome markers (TSG101 and CD81), mitochondrial marker (PHB1) and internal control (β-actin). As shown in Fig. S1B, the exosomes exhibited typical cup-shaped vesicles structure. Nanoparticle tracking analysis (NTA) showed that the size distribution of the exosomes is from 45 nm to 225 nm and centered at 122 nm, which was consistent with the typical size range of exosomes (30-150 nm) (Fig. S1C). To further investigate the performance of model exosomes preparations, the proteins extracted from HeLa cell lysates and from model exosome samples were separated by SDS-PAGE and stained with Coomassie Brilliant Blue, respectively. The distinct protein profiles of the two types of samples were shown in Fig. S1D. Clearly visible differences could be observed between 43 kDa to 95 kDa and small molecular weight range (less than 17 kDa). Then, the expression of exosomal proteins in HeLa cell lysates and model exosome samples was examined by western blotting analysis, respectively. As shown in Fig. S1E, the commonly used exosomal marker proteins, TSG101 and CD81, were highly enriched in the model exosome samples compared with HeLa cell lysates. Moreover, the mitochondrial marker, prohibitin-1 (PHB1) was not detected in the exosome fraction. The results indicated that the isolated exosomes had high purity by avoiding the interference by organelles such as mitochondria. 3 k D a 18 1 0 30 Marker 95 Supplemental 7 2 Model sample 55 43 3 Supernatant Fig. 4 2 S2 6 First wash SDS-PAGE 1 7 Second wash analysis Third wash (silver Elute stained) k D of a Marker the 18 1 0 proteins 30 9 5 Lane 1 72 isolated 55 43 Lane 2 from 3 model 4 Lane 3 26 sample Lane 4 1 7 by Lane 5 TiO 2 microspheres. Lane 6 4 le P p R le m H p sa + m + in sa e se a 2 e om iO m s -C o o β T s x + m o e n o in n ex el i r er e ei er l d se f k s s k e o a te r a a P r d C u a -C -C R a o M - l M α β H M M α E kDa kDa + 180 180 130 130 95 95 72 72 55 55 43 43 HRP 34 34 α-Casein 26 β-Casein 26 17 17 (A) (B) Supplemental Fig. S3 SDS-PAGE images of (A) α-casein (1 μg), β-casein (1 μg) and horseradish peroxidase (1 μg). (B) the model exosomal proteins (2 μg), mixture of the model exosomal proteins (2 μg)+α-casein (1 μg)+ β-casein (1 μg)+horseradish peroxidase (1 μg), and mixture of the model exosomal protein (2 μg)+α-casein (1 μg)+β-casein (1 μg)+horseradish peroxidase (1 μg) after isolated by TiO2 5 le p t h n as h m ta sh as r sa a a w e l n w d w k e er t n d e r d p s o ir t a o u ir ec h lu kDa M M S F S T E 180 130 95 72 55 43 34 26 17 r e 1 2 3 4 5 6 k e e e e e e r n n n n a a a an a an a M L L L L L L kDa 180 130 95 72 55 43 34 26 17 Supplemental Fig. S4 SDS-PAGE image of the proteins extracted from the exosomes isolated by TiO2 in three replicates (Lane 1, 3 and 5) and the corresponding residual proteins on TiO2 after exosome elution (Lane2, 4, 6). 6 p up u o ro gr g l n l g g o i in o g g g r in in in r m m t m m t .5 m m m 0 n .5 m m m 0 n 0 1 2 5 1 co 0 1 2 5 1 co Replicate 1 Replicate 1 Replicate 2 Replicate 2 Replicate 3 Replicate 3 A B Supplemental Fig. S5 Exosome enrichment effect by using (A) different TiO2 amounts and (B) different incubation time (evaluated by Western Blot analysis of TSG101). 7 TiO enriched exosome proteins A 2 mixture of rutile UC rutile anatase and anatase Marker sample <5 μm ~100 nm ~25 nm ~5 μm ~100 nm a b c d e kDa 180 130 95 72 55 43 34 26 17 the TiO2 used in our method B Supplemental Fig. S6 Exosome isolation using different commercial titanium dioxide particles. (A) SDS-PAGE image of the proteins extracted from the exosomes isolated by different titanium dioxide particles, (B) SEM images of different titanium dioxide particles. 8 Supplemental Fig. S7 Schematic of the TiO2-based method for exosomes isolation and downstream analyses 9 16 0 E x o 1 s 40 o m T ) es i e 1 O lu 20 2 va - 10 (P 0 g 10 o 8 -l 0 U 6 lt 0 ra c en 40 t ri fu g 20 a t io n 0 E E x Supplemental x o extracellular exosome o s so o extracellular space m m extracellular region e e s P blood microparticle r extracellular matrix ec ip platelet alpha granule lumen i Fig. ta very-low-density lipoprotein particle t io S8 high-density lipoprotein particle n chylomicron Gene R platelet dense granule lumen ea g E e Ontology x n blood microparticle o t so extracellular region m extracellular exosome es analysis extracellular space platelet alpha granule lumen immunoglobulin complex, circulating of membrane attackcomplex cellular very-low-density lipoprotein particle spherical high-density lipoprotein particle high-density lipoprotein particle components bloodmicroparticle extracellular region extracellular exosome extracellular space of platelet alphagranulelumen proteins high-densitylipoproteinparticle very-low-densitylipoproteinparticle extracellular matrix identified immunoglobulincomplex, circulating chylomicron in exosomes obtained by different methods 10 Supplemental Table S1. Brief Comparison of Various Exosome Isolation Methods1 Methods Assay time Exosome recovery, % Ultracentrifugation 5-9 h 2-80% (blood, serum or plasma) Density Gradient Centrifugation 16-90 h 10% (plasma or serum) Size Exclusion Chromatograph 0.3 h 40-90% (plasma) Ultrafiltration 0.5 h 10-80% (plasma) Immuno-affinity 4-20 h / Precipitation based on polymer 0.25-12 h 90% (a mixture of EVs and serum proteins) TiO2-based method 5 min for incubation, 30 min for all steps (filtration needs less than 1 ≈80% (serum) min, washing steps cost about 4 min and on microspheres exosome 93.4% (model exosomes) lysis takes about 20 min) 11 Supplemental Table S2.
Recommended publications
  • Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-Like Mouse Models: Tracking the Role of the Hairless Gene
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2006 Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene Yutao Liu University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Life Sciences Commons Recommended Citation Liu, Yutao, "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino- like Mouse Models: Tracking the Role of the Hairless Gene. " PhD diss., University of Tennessee, 2006. https://trace.tennessee.edu/utk_graddiss/1824 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Yutao Liu entitled "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Life Sciences. Brynn H. Voy, Major Professor We have read this dissertation and recommend its acceptance: Naima Moustaid-Moussa, Yisong Wang, Rogert Hettich Accepted for the Council: Carolyn R.
    [Show full text]
  • A Novel Resveratrol Analog: Its Cell Cycle Inhibitory, Pro-Apoptotic and Anti-Inflammatory Activities on Human Tumor Cells
    A NOVEL RESVERATROL ANALOG : ITS CELL CYCLE INHIBITORY, PRO-APOPTOTIC AND ANTI-INFLAMMATORY ACTIVITIES ON HUMAN TUMOR CELLS A dissertation submitted to Kent State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy by Boren Lin May 2006 Dissertation written by Boren Lin B.S., Tunghai University, 1996 M.S., Kent State University, 2003 Ph. D., Kent State University, 2006 Approved by Dr. Chun-che Tsai , Chair, Doctoral Dissertation Committee Dr. Bryan R. G. Williams , Co-chair, Doctoral Dissertation Committee Dr. Johnnie W. Baker , Members, Doctoral Dissertation Committee Dr. James L. Blank , Dr. Bansidhar Datta , Dr. Gail C. Fraizer , Accepted by Dr. Robert V. Dorman , Director, School of Biomedical Sciences Dr. John R. Stalvey , Dean, College of Arts and Sciences ii TABLE OF CONTENTS LIST OF FIGURES……………………………………………………………….………v LIST OF TABLES……………………………………………………………………….vii ACKNOWLEDGEMENTS….………………………………………………………….viii I INTRODUCTION….………………………………………………….1 Background and Significance……………………………………………………..1 Specific Aims………………………………………………………………………12 II MATERIALS AND METHODS.…………………………………………….16 Cell Culture and Compounds…….……………….…………………………….….16 MTT Cell Viability Assay………………………………………………………….16 Trypan Blue Exclusive Assay……………………………………………………...18 Flow Cytometry for Cell Cycle Analysis……………..……………....……………19 DNA Fragmentation Assay……………………………………………...…………23 Caspase-3 Activity Assay………………………………...……….….…….………24 Annexin V-FITC Staining Assay…………………………………..…...….………28 NF-kappa B p65 Activity Assay……………………………………..………….…29
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • Prediction of Human Disease Genes by Human-Mouse Conserved Coexpression Analysis
    Prediction of Human Disease Genes by Human-Mouse Conserved Coexpression Analysis Ugo Ala1., Rosario Michael Piro1., Elena Grassi1, Christian Damasco1, Lorenzo Silengo1, Martin Oti2, Paolo Provero1*, Ferdinando Di Cunto1* 1 Molecular Biotechnology Center, Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy, 2 Department of Human Genetics and Centre for Molecular and Biomolecular Informatics, University Medical Centre Nijmegen, Nijmegen, The Netherlands Abstract Background: Even in the post-genomic era, the identification of candidate genes within loci associated with human genetic diseases is a very demanding task, because the critical region may typically contain hundreds of positional candidates. Since genes implicated in similar phenotypes tend to share very similar expression profiles, high throughput gene expression data may represent a very important resource to identify the best candidates for sequencing. However, so far, gene coexpression has not been used very successfully to prioritize positional candidates. Methodology/Principal Findings: We show that it is possible to reliably identify disease-relevant relationships among genes from massive microarray datasets by concentrating only on genes sharing similar expression profiles in both human and mouse. Moreover, we show systematically that the integration of human-mouse conserved coexpression with a phenotype similarity map allows the efficient identification of disease genes in large genomic regions. Finally, using this approach on 850 OMIM loci characterized by an unknown molecular basis, we propose high-probability candidates for 81 genetic diseases. Conclusion: Our results demonstrate that conserved coexpression, even at the human-mouse phylogenetic distance, represents a very strong criterion to predict disease-relevant relationships among human genes. Citation: Ala U, Piro RM, Grassi E, Damasco C, Silengo L, et al.
    [Show full text]
  • LJELSR: a Strengthened Version of JELSR for Feature Selection and Clustering
    Article LJELSR: A Strengthened Version of JELSR for Feature Selection and Clustering Sha-Sha Wu 1, Mi-Xiao Hou 1, Chun-Mei Feng 1,2 and Jin-Xing Liu 1,* 1 School of Information Science and Engineering, Qufu Normal University, Rizhao 276826, China; [email protected] (S.-S.W.); [email protected] (M.-X.H.); [email protected] (C.-M.F.) 2 Bio-Computing Research Center, Harbin Institute of Technology, Shenzhen 518055, China * Correspondence: [email protected]; Tel.: +086-633-3981-241 Received: 4 December 2018; Accepted: 7 February 2019; Published: 18 February 2019 Abstract: Feature selection and sample clustering play an important role in bioinformatics. Traditional feature selection methods separate sparse regression and embedding learning. Later, to effectively identify the significant features of the genomic data, Joint Embedding Learning and Sparse Regression (JELSR) is proposed. However, since there are many redundancy and noise values in genomic data, the sparseness of this method is far from enough. In this paper, we propose a strengthened version of JELSR by adding the L1-norm constraint on the regularization term based on a previous model, and call it LJELSR, to further improve the sparseness of the method. Then, we provide a new iterative algorithm to obtain the convergence solution. The experimental results show that our method achieves a state-of-the-art level both in identifying differentially expressed genes and sample clustering on different genomic data compared to previous methods. Additionally, the selected differentially expressed genes may be of great value in medical research. Keywords: differentially expressed genes; feature selection; L1-norm; sample clustering; sparse constraint 1.
    [Show full text]
  • Interspecies Variation in Hominid Gut Microbiota Controls Host Gene Regulation 2 Amanda L
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.255059; this version posted August 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is 1made available under aCC-BY-NC-ND 4.0 International license. 1 Interspecies variation in hominid gut microbiota controls host gene regulation 2 Amanda L. Muehlbauer 1,2, Allison L. Richards 3, Adnan Alazizi3 , Michael Burns 4, Andres 3 Gomez 5, Jonathan B. Clayton6 ,7, Klara Petrzelkova 8,9,10, Camilla Cascardo 3, Justyna Resztak3 , 4 Xiaoquan Wen 11, Roger Pique-Regi 3,12, Francesca Luca 3,12,*, and Ran Blekhman 1,2,* 5 *Corresponding authors ( [email protected] , [email protected] ) 6 1. Department of Genetics, Cell Biology and Development, University of Minnesota, 7 Minneapolis, Minnesota, USA 8 2. Department of Ecology, Evolution and Behavior, University of Minnesota, Minneapolis, 9 Minnesota, USA 10 3. Center for Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan 11 48201, USA 12 4. Department of Biology, Loyola University, Chicago, Illinois, 60660, USA 13 5. Department of Animal Science, University of Minnesota, Saint Paul, Minnesota, USA 14 6. Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA 15 7. Department of Food Science and Technology, University of Nebraska-Lincoln, Lincoln, 16 Nebraska, USA 17 8. The Czech Academy of Sciences, Institute of Vertebrate Biology, Brno, Czech Republic 18 9. Liberec Zoo, Liberec, Czech Republic 19 10. The Czech Academy of Sciences, Institute of Parasitology, Ceske Budejovice, Czech 20 Republic 21 11.
    [Show full text]
  • Screening for Key Genes Associated with Atopic Dermatitis with DNA Microarrays
    MOLECULAR MEDICINE REPORTS 9: 1049-1055, 2014 Screening for key genes associated with atopic dermatitis with DNA microarrays ZHONG-KUI ZHANG1, YONG YANG2, SHU-RONG BAI3, GUI-ZHEN ZHANG4, TAI-HUA LIU1, ZHOU ZHOU1, CHUN-MEI WANG1, LI-JUN TANG1, JUN WANG1 and SI-XIAN HE1 Departments of 1Dermatology, 2Burns, Plastic Surgery, 3Anesthesiology and 4Information, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China Received August 15, 2013; Accepted December 16, 2013 DOI: 10.3892/mmr.2014.1908 Abstract. The aim of the present study was to identify key proteins, PIK3R1 and KRT17 are novel and promising targets genes associated with atopic dermatitis (AD) using microarray for AD therapy. data and bioinformatic analyses. The dataset GSE6012, down- loaded from the Gene Expression Omnibus (GEO) database, Introduction contains gene expression data from 10 AD skin samples and 10 healthy skin samples. Following data preprocessing, Atopic dermatitis (AD), also known as atopic eczema (AE), is a differentially expressed genes (DEGs) were identified using chronic relapsing inflammatory skin disease. It has been clas- the limma package of the R project. Interaction networks sified into 3 sequential phases: infantile, childhood and adult, were constructed comprising DEGs that showed a degree of each with characteristic physical findings (1). Approximately node of >3, >5 and >10, using the Osprey software. Functional 70% of patients have a family history of allergies (2). The enrichment and pathway enrichment analysis of the network disease has an important impact not only on patients' physical comprising all DEGs and of the network comprising DEGs and mental health, but also on the economy of society and with a high degree of node, were performed with the DAVID affected families (3).
    [Show full text]
  • Identification of Genes and Signaling Pathways Associated with Squamous Cell Carcinoma by Bioinformatics Analysis
    1382 ONCOLOGY LETTERS 11: 1382-1390, 2016 Identification of genes and signaling pathways associated with squamous cell carcinoma by bioinformatics analysis LI SHEN1,2, LINBO LIU1, ZHENYONG YANG2 and NAN JIANG2 1Department of Plastic Surgery, The First Affiliated Hospital of Zhengzhou University; 2Department of Plastic and Aesthetic Surgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China Received December 18, 2014; Accepted November 2, 2015 DOI: 10.3892/ol.2015.4051 Abstract. The present study aimed to investigate the genes Introduction and signaling pathways associated with squamous cell carci- noma (SCC) by bioinformatics analysis. For this purpose, Squamous cell carcinoma (SCC) is a histologically distinct the GSE2503 was downloaded from the Gene Expression type of cancer (1). It arises from the uncontrolled prolifera- Omnibus database, and the differentially expressed genes tion of epithelial cells or cells exhibiting cytological or tissue (DEGs) between 6 normal skin and 5 SCC samples were architectural characteristics of SC differentiation, including analyzed using the Linear Models for Microarray Data the presence of keratin, tonofilament bundles or desmosomes, package. Gene Ontology (GO) and pathway enrichment which are structures involved in cell-cell adhesion (1). SCC analysis of DEGs were performed, followed by functional occurs in numerous tissues, including the lips, mouth, esoph- annotation and construction of a protein-protein interac- agus, lungs, urinary bladder and prostate (2). Of all the cases tion (PPI) network. Subnetwork modules were subsequently of SCC, 2.5% become metastatic and lead to substantial identified and analyzed. A total of 181 DEGs, including morbidity, which constitutes a considerable economic burden 95 upregulated and 86 downregulated DEGs, were identified, to the healthcare system (3).
    [Show full text]
  • TNF-Insulin Crosstalk at the Transcription Factor GATA6 Is Revealed by a Model That Links Signaling and Transcriptomic Data Tensors
    TNF-insulin crosstalk at the transcription factor GATA6 is revealed by a model that links signaling and transcriptomic data tensors The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Chitforoushzadeh, Zeinab et al. “TNF-Insulin Crosstalk at the Transcription Factor GATA6 Is Revealed by a Model That Links Signaling and Transcriptomic Data Tensors.” Science Signaling 9, 431 (June 2016): ra59 As Published http://dx.doi.org/10.1126/SCISIGNAL.AAD3373 Publisher American Association for the Advancement of Science (AAAS) Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/117694 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike Detailed Terms http://creativecommons.org/licenses/by-nc-sa/4.0/ HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Sci Signal Manuscript Author . Author manuscript; Manuscript Author available in PMC 2017 June 07. Published in final edited form as: Sci Signal. ; 9(431): ra59. doi:10.1126/scisignal.aad3373. TNF-insulin crosstalk at the transcription factor GATA6 is revealed by a model that links signaling and transcriptomic data tensors Zeinab Chitforoushzadeh1,2, Zi Ye1,*,†, Ziran Sheng1,*, Silvia LaRue1,‡, Rebecca C. Fry3, Douglas A. Lauffenburger4, and Kevin A. Janes1,§ 1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA 2Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA 3Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 4Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA Abstract Signal -transduction networks coordinate transcriptional programs activated by diverse extracellular stimuli, such as growth factors and cytokines.
    [Show full text]
  • Differential Gene Expression Landscape of Co-Existing Cervical Pre-Cancer Lesions Using RNA-Seq
    ORIGINAL RESEARCH ARTICLE published: 26 November 2014 doi: 10.3389/fonc.2014.00339 Differential gene expression landscape of co-existing cervical pre-cancer lesions using RNA-seq Kathryn E. Royse 1, Degui Zhi 2, Michael G. Conner 3, Buffie Clodfelder-Miller 4,Vinodh Srinivasasainagendra2, Laura Kelly Vaughan2, Christine F. Skibola1, David K. Crossman5, Shawn Levy 6 and Sadeep Shrestha1* 1 Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA 2 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA 3 Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA 4 Cellular and Molecular Neuropathology Core, University of Alabama at Birmingham, Birmingham, AL, USA 5 Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA 6 Hudson Alpha Institute for Biotechnology, Huntsville, AL, USA Edited by: Genetic changes occurring in different stages of pre-cancer lesions reflect causal events Mike Eccles, University of Otago, initiating and promoting the progression to cancer. Co-existing pre-cancerous lesions New Zealand including low- and high-grade squamous intraepithelial lesion (LGSIL and HGSIL), and adja- Reviewed by: Cristin Gregor Print, University of cent “normal” cervical epithelium from six formalin-fixed paraffin-embedded samples were Auckland, New Zealand selected. Tissues from these 18 samples were isolated using laser-capture microdissec- Aniruddha Chatterjee, University of tion, RNA was extracted and sequenced. RNA-sequencing generated 2.4 billion raw reads Otago, New Zealand in 18 samples, of which ~50.1% mapped to known and annotated genes in the human *Correspondence: genome. There were 40 genes up-regulated and 3 down-regulated (normal to LGSIL) in at Sadeep Shrestha, Department of Epidemiology, University of Alabama least one-third of the sample pairs (same direction and FDR p < 0.05) including S100A7 at Birmingham, 1665 University Blvd, and KLK6.
    [Show full text]
  • The LINC Complex Transmits Integrin- Dependent Tension to the Nuclear
    RESEARCH ARTICLE The LINC complex transmits integrin- dependent tension to the nuclear lamina and represses epidermal differentiation Emma Carley1†, Rachel M Stewart1†, Abigail Zieman2†, Iman Jalilian1, Diane E King3, Amanda Zubek4, Samantha Lin2, Valerie Horsley2,4*, Megan C King1,2* 1Department of Cell Biology, Yale School of Medicine, New Haven, United States; 2Department of Molecular, Cell and Developmental Biology, Yale University, New Haven, United States; 3Sunnycrest Bioinformatics, Flemington, United States; 4Department of Dermatology, Yale School of Medicine, New Haven, United States Abstract While the mechanisms by which chemical signals control cell fate have been well studied, the impact of mechanical inputs on cell fate decisions is not well understood. Here, using the well-defined system of keratinocyte differentiation in the skin, we examine whether and how direct force transmission to the nucleus regulates epidermal cell fate. Using a molecular biosensor, we find that tension on the nucleus through linker of nucleoskeleton and cytoskeleton (LINC) complexes requires integrin engagement in undifferentiated epidermal stem cells and is released during differentiation concomitant with decreased tension on A-type lamins. LINC complex ablation in mice reveals that LINC complexes are required to repress epidermal differentiation in vivo and in vitro and influence accessibility of epidermal differentiation genes, suggesting that force transduction from engaged integrins to the nucleus plays a role in maintaining keratinocyte *For correspondence: progenitors. This work reveals a direct mechanotransduction pathway capable of relaying adhesion- [email protected] (VH); specific signals to regulate cell fate. [email protected] (MCK) †These authors contributed equally to this work Competing interest: See Introduction page 22 Physical forces and the architecture of the extracellular environment are an emerging area of cell Funding: See page 22 fate regulation (Discher et al., 2009).
    [Show full text]
  • Study on the Selection of the Targets of Esophageal Carcinoma and Interventions of Ginsenosides Based on Network Pharmacology and Bioinformatics
    Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2020, Article ID 4821056, 10 pages https://doi.org/10.1155/2020/4821056 Research Article Study on the Selection of the Targets of Esophageal Carcinoma and Interventions of Ginsenosides Based on Network Pharmacology and Bioinformatics Xin Yang , Yahui Li , and Haibing Qian Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China Correspondence should be addressed to Haibing Qian; [email protected] Received 16 January 2020; Revised 3 May 2020; Accepted 27 May 2020; Published 24 June 2020 Academic Editor: Armando Zarrelli Copyright © 2020 Xin Yang et al. ,is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Esophageal carcinoma (ESCA) is not only a threat to people’s health but also the sixth most common cause of cancer- related mortality worldwide. Methods. In this study, the key targets of ESCA are screened through GeneCards and DisGeNET databases combined with the Gene Expression Omnibus (GEO) database (GSE1420 and GSE20347). ,en, data associated with ESCA samples are downloaded from ,e Cancer Genome Atlas (TCGA) database for integrated analysis. Moreover, the effect of epithelial cell adhesion molecule (EpCAM) expression on the survival of patients with ESCA is evaluated by Kaplan–Meier and Cox analyses. ,e virtual screening is carried out using a Suflex-Dock molecular docking module. ,e chemical components, which have been well bound to EpCAM, are screened out based on a total score >5 as a threshold. Ginsenosides and EpCAM are analyzed by LigPlot + v.2.2 software to identify the binding sites.
    [Show full text]